Novo Nordisk Stock is on Sale- A Cash Flow Giant
Despite a steep 65% drop from its all-time high of 145.99 a share in the prior 12 months, Novo Nordisk remains one of the most operationally sound businesses on the planet. As an investor, you are getting exposure to the booming GLP-1 drug market and the stable, cash-rich insulin and diabetes care business, serving a…
